|
|
14405 21st Avenue North
Minneapolis, MN 55447 USA
phone:(763) 475-1400
fax:(763) 475-1443
|
|
| Symbol |
ULGX |
| Exchange |
Nasdaq |
| Founded |
1991 |
| Employees |
90 |
|
|
| www.urologix.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. |
|
| Management |
| Stryker Warren jr, CEO
Greg Fluet, EVP & COO
Brian Smrdel, CFO
Ralph Cardinal, VP Research & Development |
| |
|
|
|
|
|
|
|
| Keywords |
| urology, benign prostatic hyperplasia, bph, urological devices, prostate disease, enlarged prostate, lower urinary tract symptoms, luts, prostate |
|
|
|
| Description |
|
Urologix, Inc., based in Minneapolis, Minnesota develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. Urologix has developed and offers non-surgical, catheter-based treatments that use proprietary microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix is a leader in less invasive technology for the treatment of BPH, with more than 225,000 patients treated to date. |
|
| Products / Services |
Urologix has developed and offers non-surgical, catheter-based treatments that use proprietary microwave technology for the treatment of benign prostatic hyperplasia (BPH).
|
|
| Technology / Differentiation |
| Urologix' patented Cooled ThermoTherapy technology delivers precisely targeted microwave energy that heats and destroys enlarged prostatic tissue while unique cooling mechanisms protect surrounding healthy tissue and enhances patient comfort. Urologix's patented Cooled ThermoTherapy technology is indicated to relieve the obstructive component of BPH, while other microwave devices are not. Urologix' 5 year durability data shows 2/3 of all patients treated free from any subsequent intervention to include drugs, surgery or other procedure. |
|
| Market / Customers |
Urologists treating BPH and patients suffering from BPH.
|
|
| Competitors / Substitutes / Alternatives |
Alternatives include: chronic BPH medication (Flomax /Boehringer Ingelheim International, Avodart/GlaxoSmithKline), low energy microwave (Thermatrx /American Medical Systems, Prolieve/Boston Scientific), Coretherm/Prostalund, RF needle ablation (Postiva/Medtronic), and surgical procedures (TURP, Greenlight/American Medical Systems).
|
|
| Status |
| Publically traded; proprietary technology that is FDA approved for the treatment of benign prostatic hyperplasia. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members